Physiological matrix metalloproteinase concentrations in serum during childhood and adolescence, using Luminex® Multiplex technology
-
Kathryn M. Thrailkill
Abstract
Matrix metalloproteinases are a family of zinc-dependent proteinases which are involved in the breakdown and remodeling of extracellular matrix. As children grow and adolescents reach pubescence, their bodies undergo changes that require age-related morphogenesis of the extracellular matrix, possibly requiring unique patterns of matrix metalloproteinase (MMP) expression during periods of rapid tissue growth (i.e., childhood) or accelerated tissue remodeling and expansion (i.e., adolescence). Therefore, we have characterized age-specific and gender-specific differences in circulating concentrations of MMPs (specifically MMP-1, -2, -3, -8 and -9) in 189 serum samples obtained from healthy subjects, aged 2–18 years. MMP concentrations were measured using Fluorokine® MultiAnalyte Profiling kits and a Luminex® Bioanalyzer, as well as by commercial ELISA. Serum levels of MMP-1, -2, -3, -8, and -9 in healthy pediatric subjects represent log-normal distributions. MMP-2 was significantly negatively correlated with age (r=−0.29; p<0.001), while MMP-3 was significantly positively correlated with age (r=0.38; p<0.001). Although plasma, not serum, is considered the appropriate blood sample for measurement of MMP-8 and -9, serum levels of MMP-8 and -9 were also found to be highly positively correlated with each other (r=0.76; p<0.01). MMP results obtained by Fluorokine® MultiAnalyte Profiling methods correlated well with conventional ELISA methods and use of this technology provided several advantages over ELISA.
References
1. Werb Z. ECM and cell surface proteolysis: regulating cellular ecology. Cell 1997; 91:439–42.10.1016/S0092-8674(00)80429-8Suche in Google Scholar
2. Mott JD, Werb Z. Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol 2004; 16:558–64.10.1016/j.ceb.2004.07.010Suche in Google Scholar
3. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001; 17:463–516.10.1146/annurev.cellbio.17.1.463Suche in Google Scholar
4. Van Noort JM, Amor S. Cell biology of autoimmune diseases. Int Rev Cytol 1998; 178:127–206.10.1016/S0074-7696(08)62137-3Suche in Google Scholar
5. Nagase H. Matrix metalloproteinases. London: Taylor and Francis, 1996:153–204.Suche in Google Scholar
6. Okada Y, Takeuchi N, Tomita K, Nakanishi I, Nagase H. Immunolocalization of matrix metalloproteinase 3 (stromelysin) in rheumatoid synovioblasts (B cells): correlation with rheumatoid arthritis. Ann Rheum Dis 1989; 48:645–53.10.1136/ard.48.8.645Suche in Google Scholar
7. Schoenhagen P, Vince DG, Ziada KM, Kapadia SR, Lauer MA, Crowe TD, et al. Relation of matrix-metalloproteinase 3 found in coronary lesion samples retrieved by directional coronary atherectomy to intravascular ultrasound observations on coronary remodeling. Am J Cardiol 2002; 89:1354–9.10.1016/S0002-9149(02)02346-9Suche in Google Scholar
8. El-Gindy I, El Rahman AT, El-Alim MA, Zaki SS. Diagnostic potential of serum matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as non-invasive markers of hepatic fibrosis in patients with HCV related chronic liver disease. Egypt J Immunol 2003; 10:27–35.Suche in Google Scholar
9. Pasieka Z, Stepien H, Czyz W, Pomorski L, Kuzdak K. Concentration of metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in the serum of patients with benign and malignant thyroid tumours treated surgically. Endocr Regul 2004; 38:57–63.Suche in Google Scholar
10. Huang HF, Hong LH, Tan Y, Sheng JZ. Matrix metalloproteinase 2 is associated with changes in steroid hormones in the sera and peritoneal fluid of patients with endometriosis. Fertil Steril 2004; 81:1235–9.10.1016/j.fertnstert.2003.10.027Suche in Google Scholar PubMed
11. Abou-Raya S, Naim A, Marzouk S. Cardiac matrix remodelling in congestive heart failure: the role of matrix metalloproteinases. Clin Invest Med 2004; 27:93–100.Suche in Google Scholar
12. Lynch JR, Blessing R, White WD, Grocott HP, Newman MF, Laskowitz DT. Novel diagnostic test for acute stroke. Stroke 2004; 35:57–63.10.1161/01.STR.0000105927.62344.4CSuche in Google Scholar PubMed
13. Reynolds MA, Kirchick HJ, Dahlen JR, Anderberg JM, McPherson PH, Nakamura KK, et al. Early biomarkers of stroke. Clin Chem 2003; 49:1733–9.10.1373/49.10.1733Suche in Google Scholar PubMed
14. Tazaki T, Minoguchi K, Yokoe T, Samson KT, Minoguchi H, Tanaka A, et al. Increased levels and activity of matrix metalloproteinase-9 in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2004; 170:1354–9.10.1164/rccm.200402-193OCSuche in Google Scholar PubMed
15. Renko J, Kalela A, Jaakkola O, Laine S, Hoyhtya M, Alho H, et al. Serum matrix metalloproteinase-9 is elevated in men with a history of myocardial infarction. Scand J Clin Lab Invest 2004; 64:255–61.10.1080/00365510410006054Suche in Google Scholar
16. Demestre M, Parkin-Smith G, Petzold A, Pullen AH. The pro and the active form of matrix metalloproteinase-9 is increased in serum of patients with amyotrophic lateral sclerosis. J Neuroimmunol 2005; 159:146–54.10.1016/j.jneuroim.2004.09.015Suche in Google Scholar
17. Kuyvenhoven JP, Verspaget HW, Gao Q, Ringers J, Smit VT, Lamers CB, et al. Assessment of serum matrix metalloproteinases MMP-2 and MMP-9 after human liver transplantation: increased serum MMP-9 level in acute rejection. Transplantation 2004; 77:1646–52.10.1097/01.TP.0000131170.67671.75Suche in Google Scholar
18. Zucker S, Lysik RM, Zarrabi MH, Greenwald RA, Gruber B, Tickle SP, et al. Elevated plasma stromelysin levels in arthritis. J Rheumatol 1994; 21:2329–33.Suche in Google Scholar
19. Brinckerhoff CE, Matrisian LM. Matrix metalloproteinases: a tail of a frog that became a prince. Nat Rev Mol Cell Biol 2002; 3:207–14.10.1038/nrm763Suche in Google Scholar
20. Stamenkovic I. Extracellular matrix remodelling: the role of matrix metalloproteinases. J Pathol 2003; 200:448–64.10.1002/path.1400Suche in Google Scholar
21. Styne DM. Puberty, obesity and ethnicity. Trends Endocrinol Metab 2004; 15:472–8.10.1016/j.tem.2004.10.008Suche in Google Scholar
22. Zucker S, Doshi K, Cao J. Measurement of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMP) in blood and urine: potential clinical applications. Adv Clin Chem 2004; 38:37–85.10.1016/S0065-2423(04)38002-9Suche in Google Scholar
23. Thrailkill KM, Kumar S, Rosenberg CK, Auten KJ, Fowlkes JL. Characterization of matrix metalloproteinases in human urine: alterations during adolescence. Pediatr Nephrol 1999; 13:223–9.10.1007/s004670050597Suche in Google Scholar
24. Mora S, Prinster C, Proverbio MC, Bellini A, de Poli SC, Weber G, et al. Urinary markers of bone turnover in healthy children and adolescents: age-related changes and effect of puberty. Calcif Tissue Int 1998; 63:369–74.10.1007/s002239900542Suche in Google Scholar
25. Bord S, Horner A, Beeton CA, Hembry RM, Compston JE. Tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) distribution in normal and pathological human bone. Bone 1999; 24:229–35.10.1016/S8756-3282(98)00174-4Suche in Google Scholar
26. Bord S, Horner A, Hembry RM, Compston JE. Stromelysin-1 (MMP-3) and stromelysin-2 (MMP-10) expression in developing human bone: potential roles in skeletal development. Bone 1998; 23:7–12.10.1016/S8756-3282(98)00064-7Suche in Google Scholar
27. Werb Z, Chin JR. Extracellular matrix remodeling during morphogenesis. Ann NY Acad Sci 1998; 857:110–8.10.1111/j.1749-6632.1998.tb10111.xSuche in Google Scholar PubMed
28. Weiss S, Baumgart R, Jochum M, Strasburger CJ, Bidlingmaier M. Systemic regulation of distraction osteogenesis: a cascade of biochemical factors. J Bone Miner Res 2002; 17:1280–9.10.1359/jbmr.2002.17.7.1280Suche in Google Scholar PubMed
29. Uusitalo H, Hiltunen A, Soderstrom M, Aro HT, Vuorio E. Expression of cathepsins B, H, K, L, and S and matrix metalloproteinases 9 and 13 during chondrocyte hypertrophy and endochondral ossification in mouse fracture callus. Calcif Tissue Int 2000; 67:382–90.10.1007/s002230001152Suche in Google Scholar PubMed
30. Fata JE, Ho AT, Leco KJ, Moorehead RA, Khokha R. Cellular turnover and extracellular matrix remodeling in female reproductive tissues: functions of metalloproteinases and their inhibitors. Cell Mol Life Sci 2000; 57:77–95.10.1007/s000180050500Suche in Google Scholar PubMed
31. Stygar D, Wang H, Vladic YS, Ekman G, Eriksson H, Sahlin L. Increased level of matrix metalloproteinases 2 and 9 in the ripening process of the human cervix. Biol Reprod 2002; 67:889–94.10.1095/biolreprod.102.005116Suche in Google Scholar PubMed
32. Lenhart JA, Ryan PL, Ohleth KM, Palmer SS, Bagnell CA. Relaxin increases secretion of tissue inhibitor of matrix metalloproteinase-1 and -2 during uterine and cervical growth and remodeling in the pig. Endocrinology 2002; 143:91–8.10.1210/endo.143.1.8562Suche in Google Scholar PubMed
33. Dong JC, Dong H, Campana A, Bischof P. Matrix metalloproteinases and their specific tissue inhibitors in menstruation. Reproduction 2002; 123:621–31.10.1530/rep.0.1230621Suche in Google Scholar PubMed
34. Lochter A. Plasticity of mammary epithelia during normal development and neoplastic progression. Biochem Cell Biol 1998; 76:997–1008.10.1139/o99-010Suche in Google Scholar
35. Sang QX, Stetler-Stevenson WG, Liotta LA, Byers SW. Identification of type IV collagenase in rat testicular cell culture: influence of peritubular-Sertoli cell interactions. Biol Reprod 1990; 43:956–64.10.1095/biolreprod43.6.956Suche in Google Scholar PubMed
36. Anne-Valerie R, Christelle D, Yannick F, Norbert P, Marc P, Dominique H. Human growth hormone stimulates proteinase activities of rabbit bone cells via IGF-I. Biochem Biophys Res Commun 2000; 268:875–81.10.1006/bbrc.2000.2079Suche in Google Scholar
37. Yoon A, Hurta RA. Insulin like growth factor-1 selectively regulates the expression of matrix metalloproteinase-2 in malignant H-ras transformed cells. Mol Cell Biochem 2001; 223:1–6.10.1023/A:1017549222677Suche in Google Scholar
38. Hui W, Rowan AD, Cawston T. Insulin-like growth factor 1 blocks collagen release and down regulates matrix metalloproteinase-1, -3, -8, and -13 mRNA expression in bovine nasal cartilage stimulated with oncostatin M in combination with interleukin 1alpha. Ann Rheum Dis 2001; 60:254–61.10.1136/ard.60.3.254Suche in Google Scholar
39. Lupia E, Elliot SJ, Lenz O, Zheng F, Hattori M, Striker GE, et al. IGF-1 decreases collagen degradation in diabetic NOD mesangial cells: implications for diabetic nephropathy. Diabetes 1999; 48:1638–44.10.2337/diabetes.48.8.1638Suche in Google Scholar
40. Li SC, Chen GF, Chan PS, Choi HL, Ho SM, Chan FL. Altered expression of extracellular matrix and proteinases in Noble rat prostate gland after long-term treatment with sex steroids. Prostate 2001; 49:58–71.10.1002/pros.1118Suche in Google Scholar
41. Liao EY, Luo XH, Deng XG, Wu XP. Effects of 17beta-estradiol on the expression of membrane type 1 matrix metalloproteinase (MT1-MMP) and MMP-2 in human osteoblastic MG-63 cell cultures. J Endocrinol Invest 2001; 24:876–81.10.1007/BF03343945Suche in Google Scholar
42. Wingrove CS, Garr E, Godsland IF, Stevenson JC. 17beta-oestradiol enhances release of matrix metalloproteinase-2 from human vascular smooth muscle cells. Biochim Biophys Acta 1998; 1406:169–74.10.1016/S0925-4439(97)00097-5Suche in Google Scholar
43. Vignali DA. Multiplexed particle-based flow cytometric assays. J Immunol Methods 2000; 243:243–55.10.1016/S0022-1759(00)00238-6Suche in Google Scholar
©2005 by Walter de Gruyter Berlin New York
Artikel in diesem Heft
- Contents Volume 43, 2005
- Author Index
- Subject Index
- ProteinChips: the essential tools for proteomic biomarker discovery and future clinical diagnostics
- Protein profiling as a diagnostic tool in clinical chemistry: a review
- Protein biochip systems for the clinical laboratory
- Automation of biochip array technology for quality results
- SELDI-TOF-MS proteomics of breast cancer
- Protein microarrays for the diagnosis of allergic diseases: state-of-the-art and future development
- Separation of human serum proteins using the Beckman-Coulter PF2D™ system: analysis of ion exchange-based first dimension chromatography
- Rapid, accurate genotyping of alcohol dehydrogenase-1B and aldehyde dehydrogenase-2 based on the use of denaturing HPLC
- APOA1 polymorphisms are associated with variations in serum triglyceride concentrations in hypercholesterolemic individuals
- Simple PCR heteroduplex, SSCP mutation screening methods for the detection of novel catalase mutations in Hungarian patients with type 2 diabetes mellitus
- Glycogen phosphorylase BB in acute coronary syndromes
- Alteration in serum leptin correlates with alterations in serum N-telopeptide of collagen type I and serum osteocalcin during the progression of osteoporosis in ovariectomized rats
- Glycemic control in diabetes in three Danish counties
- Atorvastatin suppresses homocysteine formation in stimulated human peripheral blood mononuclear cells
- Buprenorphine detection in biological samples
- The effect of thyroid antibody positivity on reference intervals for thyroid stimulating hormone (TSH) and free thyroxine (FT4) in an aged population
- High-affinity antibodies in a new immunoassay for plasma tissue factor: reduction in apparent intra-individual variation
- Physiological matrix metalloproteinase concentrations in serum during childhood and adolescence, using Luminex® Multiplex technology
- Sensitive immunoassays for the autoantibodies reacting against citrullinated carboxy-terminal telopeptides of type I and type II collagens in patients with rheumatoid arthritis
- Acknowledgement
Artikel in diesem Heft
- Contents Volume 43, 2005
- Author Index
- Subject Index
- ProteinChips: the essential tools for proteomic biomarker discovery and future clinical diagnostics
- Protein profiling as a diagnostic tool in clinical chemistry: a review
- Protein biochip systems for the clinical laboratory
- Automation of biochip array technology for quality results
- SELDI-TOF-MS proteomics of breast cancer
- Protein microarrays for the diagnosis of allergic diseases: state-of-the-art and future development
- Separation of human serum proteins using the Beckman-Coulter PF2D™ system: analysis of ion exchange-based first dimension chromatography
- Rapid, accurate genotyping of alcohol dehydrogenase-1B and aldehyde dehydrogenase-2 based on the use of denaturing HPLC
- APOA1 polymorphisms are associated with variations in serum triglyceride concentrations in hypercholesterolemic individuals
- Simple PCR heteroduplex, SSCP mutation screening methods for the detection of novel catalase mutations in Hungarian patients with type 2 diabetes mellitus
- Glycogen phosphorylase BB in acute coronary syndromes
- Alteration in serum leptin correlates with alterations in serum N-telopeptide of collagen type I and serum osteocalcin during the progression of osteoporosis in ovariectomized rats
- Glycemic control in diabetes in three Danish counties
- Atorvastatin suppresses homocysteine formation in stimulated human peripheral blood mononuclear cells
- Buprenorphine detection in biological samples
- The effect of thyroid antibody positivity on reference intervals for thyroid stimulating hormone (TSH) and free thyroxine (FT4) in an aged population
- High-affinity antibodies in a new immunoassay for plasma tissue factor: reduction in apparent intra-individual variation
- Physiological matrix metalloproteinase concentrations in serum during childhood and adolescence, using Luminex® Multiplex technology
- Sensitive immunoassays for the autoantibodies reacting against citrullinated carboxy-terminal telopeptides of type I and type II collagens in patients with rheumatoid arthritis
- Acknowledgement
